Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion type Assertion NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_head.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion description "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion evidence source_evidence_literature NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion SIO_000772 21555683 NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion wasDerivedFrom befree-2016 NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion wasGeneratedBy ECO_0000203 NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.